Paper3917709
Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
Hancock KW and 4 others. Br Med J (Clin Res Ed), 1985. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas. Papers, record 3917709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3917709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bromocriptine | Major topic |
| Pituitary Neoplasms | Major topic |
| Prolactin | Major topic |
| Adult | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Pregnancy | |
| Pregnancy Complications, Neoplastic |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7397087 | Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression. | Br J Obstet Gynaecol | 1980 | https://conductscience.org/library/papers/7397087 | PubMed |
| 2 | 7105430 | Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea. | Clin Endocrinol (Oxf) | 1982 | https://conductscience.org/library/papers/7105430 | PubMed |
| 3 | 6866052 | Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6866052 | PubMed |
| 4 | 6146751 | Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography. | Lancet | 1984 | https://conductscience.org/library/papers/6146751 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22828169 | Treatment of hyperprolactinemia: a systematic review and meta-analysis. | Syst Rev | 2012 | https://conductscience.org/library/papers/22828169 | PubMed |
| 3933747 | Treatment of presumed prolactinoma by transsphenoidal operation: early and late results. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3933747 | PubMed |
| 2906549 | Hyperprolactinaemia. | BMJ | 1988 | https://conductscience.org/library/papers/2906549 | PubMed |
| 2188044 | [Terguride in hyperprolactinemia--experiences with 5 patients]. | Klin Wochenschr | 1990 | https://conductscience.org/library/papers/2188044 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3917709
GET https://conductscience.org/api/papers/v1/3917709/authors